HER-2/neu 369-377 (HLA-A*02:01)
€57.50 *
Prices plus VAT plus shipping costs
Delivery time 2-3 days
sterile and endotoxin free
Delivery Format: The product is supplied freeze dried.
- Order number: EP07858_1
KIFGSLAFL is a linear peptidic epitope studied as part of Receptor tyrosine-protein kinase... more
Product information "HER-2/neu 369-377 (HLA-A*02:01)"
KIFGSLAFL is a linear peptidic epitope studied as part of Receptor tyrosine-protein kinase erbB-2 from Rattus norvegicus (brown rat) and Receptor tyrosine-protein kinase erbB-2 from Homo sapiens (human).ï¾ This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assays HER-2/neu 369-377 peptide KIFGSLAFL (HLA-A*02:01) for stimulation of T-cells. Single peptide (KIFGSLAFL) for stimulation of human Her-2/neu-specific CD8+ T-cells.
Available downloads:
####
Sequence: | KIFGSLAFL | |
Gene: | ERBB2 | |
Delivery: | 2-3 days | |
C-Terminus: | OH | |
N-Terminus: | H | |
Purity: | 95% | |
Amount: | 1 mg | |
Counter Ion: | TFA | |
Protein: | Receptor tyrosine-protein kinase erbB-2 | |
Species: | Human | |
Allele: | HLA-A*02:01 | |
Application : | T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response | |
Indication : | Cancer |
Dokumente - Protokolle - Downloads more
Protocols and Tips
Data sheets
Viewed